SICMAFARMA

ACTIVE SUBSTANCE CONCENTRATION: 10mg/mL PHARMACEUTICAL FORM: Solution for injection. ROUTE OF ADMINISTRATION: IV – Intravenous PRODUCT PRESENTATION: Box x 1 vial of transparent glass type I. VALIDITY TIME: 2 years from manufacture. LABORATORY MANUFACTURER: Naprod Life Sciences Pvt. Ltd COUNTRY OF ORIGIN: India. EXPORTER: Advanov Pharma Pvt Ltd. STORAGE: Store below 30°C in your original container and packaging. ATC: N01AX10. INDICATIONS AND/OR THERAPEUTIC USE: A short-acting intravenous anesthetic suitable for the induction and maintenance of general anesthesia. It can be used for sedation of adult patients undergoing mechanical ventilation in the intensive care unit. Conscious sedation for short invasive procedures, surgical and diagnostic processes. Propofol 1% injection is a short-acting intravenous general anesthetic for: • Induction and maintenance of general anesthesia in adults and children> 1 month. • Sedation for diagnostic and surgical procedures, alone or combined with local or regional anesthesia in adults and children> 1 month. • Sedation of ventilated patients> 16 years in the intensive care unit. CONTRAINDICATIONS: They are contraindicated: In patients with known hypersensitivity to Propofol or any of the excipients. Patients 16 years of age or younger for sedation in intensive care. For sedation of children of all ages with whooping cough or epiglottitis receiving intensive care. Allergy to soybean, egg, peanut and peanut oil.<br />
<br />
*AUTHORIZED PURCHASE FOR PROFESSIONAL USE ONLY - SUBJECTED TO EACH COUNTRY'S REGULAMENTS